ID

16730

Beskrivning

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Concomitant Medications

Länk

https://clinicaltrials.gov/ct2/show/NCT00373425

Nyckelord

Versioner (2)
  1. 2016-08-02 2016-08-02 -
  2. 2016-08-03 2016-08-03 - Julian Varghese
Uppladdad den

3 augusti 2016

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0
Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Tillbaka till modellkommentarer
Itemgroup-kommentar för :

Item-kommentar för :

  • Senaste
  • Äldsta
  • Önskad
  • Senaste
    • Senaste
    • Äldsta
    • Önskad

    Inga kommentarer

    Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

    Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

    Engelsk

    Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

    1 Formulär  
    Concomitant Medications
    Beskrivning

    Concomitant Medications

    Concomitant Medication
    Beskrivning

    Concomitant Medication

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C2347852
    Medications
    Beskrivning

    Medications

    Medication (Use generic name when possible)
    Beskrivning

    Concomitant Medication

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2347852
    Prophylaxis
    Beskrivning

    Indication Prophylaxis

    Datatyp

    boolean

    Alias
    UMLS CUI [1,1]
    C2826696
    UMLS CUI [1,2]
    C0199176
    Indication
    Beskrivning

    Indication

    Datatyp

    text

    Alias
    UMLS CUI [1]
    C2826696
    Date started: Prestudy
    Beskrivning

    Concomitant Medication Start Date

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C2826734
    Date started
    Beskrivning

    Concomitant Medication Start Date

    Datatyp

    date

    Alias
    UMLS CUI [1]
    C2826734
    Date stopped: Post treatment
    Beskrivning

    Concomitant Medication End Date

    Datatyp

    boolean

    Alias
    UMLS CUI [1]
    C2826744
    Date stopped
    Beskrivning

    Concomitant Medication End Date

    Datatyp

    date

    Alias
    UMLS CUI [1]
    C2826744
    Tillbaka till toppen

    Similar models

    Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

    1 Formulär
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datatyp
    Alias
    Item Group
    Concomitant Medications
    Concomitant Medication
    Item
    Concomitant Medication
    boolean
    C2347852 (UMLS CUI [1])
    Item Group
    Medications
    Concomitant Medication
    Item
    Medication (Use generic name when possible)
    text
    C2347852 (UMLS CUI [1])
    Indication Prophylaxis
    Item
    Prophylaxis
    boolean
    C2826696 (UMLS CUI [1,1])
    C0199176 (UMLS CUI [1,2])
    Indication
    Item
    Indication
    text
    C2826696 (UMLS CUI [1])
    Concomitant Medication Start Date
    Item
    Date started: Prestudy
    boolean
    C2826734 (UMLS CUI [1])
    Concomitant Medication Start Date
    Item
    Date started
    date
    C2826734 (UMLS CUI [1])
    Concomitant Medication End Date
    Item
    Date stopped: Post treatment
    boolean
    C2826744 (UMLS CUI [1])
    Concomitant Medication End Date
    Item
    Date stopped
    date
    C2826744 (UMLS CUI [1])
    Tillbaka till toppen 

    Hjälp

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial